🇺🇸 FDA
Patent

US 12384775

Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors

granted A61PA61P35/00A61P37/00

Quick answer

US patent 12384775 (Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P35/00, A61P37/00